Completed
A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19
J2W-MC-PYAA - ClinicalTrials.gov - NCT04411628
The purpose of this study is to test the safety and tolerability of LY3819253 when it is given by injection into a vein to participants hospitalized with COVID-19. Blood tests will be done to check how much LY3819253 is in the bloodstream and how long the body takes to eliminate it.
How long will I be in the trial?
Participation could last about 8 weeks and may include up to 15 visits in the hospital or in the home.
Completed
A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19
J2W-MC-PYAA - ClinicalTrials.gov - NCT04411628
The purpose of this study is to test the safety and tolerability of LY3819253 when it is given by injection into a vein to participants hospitalized with COVID-19. Blood tests will be done to check how much LY3819253 is in the bloodstream and how long the body takes to eliminate it.
How long will I be in the trial?
Participation could last about 8 weeks and may include up to 15 visits in the hospital or in the home.
Key Requirements
Age :
18-75
Sex:
All
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18-75
Sex
All
Participants must
Participants must have at least moderate COVID-19 illness
Participants must have at least one of the following: fever, cough, sore throat, loss of taste or smell, weakness, headache, muscle pain, shortness of breath, or difficulty breathing
Participants must be in the hospital
Participants must NOT
Participants must not be on a ventilator (a type of machine that helps people breathe when they are very sick)
Participants must not be residents in nursing homes or long-term care centers before coming to the hospital
Participants must not have a serious medical condition or infection other than COVID-19
Participants must not be pregnant or breastfeeding
Trial Summary
Conditions the trial is for
COVID-19 (Coronavirus)
What the trial is testing?
LY3819253, LY-CoV555
Could I receive a Placebo?
yes
Enrollment Goal
40
Trial Dates
March 2020 - August 2020
Trial Phase
1
Enter your postal code to find the nearest site
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18-75
Sex
All
Participants must
Participants must have at least moderate COVID-19 illness
Participants must have at least one of the following: fever, cough, sore throat, loss of taste or smell, weakness, headache, muscle pain, shortness of breath, or difficulty breathing
Participants must be in the hospital
Participants must NOT
Participants must not be on a ventilator (a type of machine that helps people breathe when they are very sick)
Participants must not be residents in nursing homes or long-term care centers before coming to the hospital
Participants must not have a serious medical condition or infection other than COVID-19
Participants must not be pregnant or breastfeeding
Trial Summary
Conditions the trial is for
COVID-19 (Coronavirus)
What the trial is testing?
LY3819253, LY-CoV555
Could I receive a Placebo?
yes
Enrollment Goal
40
Trial Dates
March 2020 - August 2020
Trial Phase
1
Not the right fit? Sign up to receive updates on new trials.
Trial Locations
Hide locations not currently recruiting
Enter your postal code to see sites near you
COVID-19 (Coronavirus) Resources
COVID-19 Research
COVID-19 is caused by SARS-CoV-2, a novel coronavirus. Because it is a relatively new disease, scientists and physicians do not know much about it, and currently, there are not many medicines to treat it. That’s why we need clinical research—to test potential new treatments for COVID-19. Read on to see if a clinical trial may be right for you.
